Further, we successfully extended our findings to early detection of lung cancer by also demonstrating reduced expression of the subfamily in airways of smokers with lung cancer relative to those without the malignancy (from an independent cohort) thus providing a non-linear proof-of-principle validation of reduced expression of TBX2 subfamily in early-stage lung cancer. This evidence concerns the gene TBX2 and lung carcinoma.